Vandria SA

Switzerland

 
Total IP 14
Total IP Rank # 108,234
IP Activity Score 2.1/5.0    17
IP Activity Rank # 49,555
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

7 1
1 0
4 1
0
 
Last Patent 2024 - Use of urolithin derivatives in ...
First Patent 2022 - Urolithin derivatives and method...
Last Trademark 2021 - VANDRIA
First Trademark 2021 - VANDRIA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis. Disclosed are me...
Invention Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis. Disclosed are met...
2023 Invention Urolithin derivatives and methods of use thereof. Disclosed are compounds, compositions, and met...
Invention Therapeutic uses of urolithin derivatives. Disclosed are methods for treating a neuromuscular di...
Invention Urolithin derivatives and therapeutic uses. Disclosed are compounds, compositions, and methods u...
Invention Therapeutic uses of urolithin derivatives. Disclosed are Urolithin derivatives for use in methods...
Invention Urolithin and fluorene derivatives for inhibiting ferroptosis. The application relates to urolith...
2022 Invention Urolithin derivatives and methods of use thereof. Disclosed are compounds, compositions, and meth...
2021 G/S Pharmaceutical preparations. Pharmaceutical research and development services.
G/S Pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovas...